CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will present a corporate overview at the Noble Financial Capital Market’s Fifth Annual Equity Conference on Monday, June 8, at 10:25 a.m. (EDT) at The Hard Rock Hotel in Hollywood, FL.
